Therefore, our work aimed to evaluate the impact of B1R and B2R activation on migration and invasion, examine their associated mechanisms in breast cancer cells, and study the effect of the antagonism of both receptors in vivo. This evidence concerns the gene BDKRB2 and breast carcinoma.